Delivery Order SPE2DB24D3013-SPE2DB25FFQPD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a $2,917.12 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count units). This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $1,216.66 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) on September 4, 2025, with an ultimate completion date of September 5, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,854.29 delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of April 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a contract value of $1,150.92. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.24 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a single delivery order issued under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,389.74 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 20 mg capsules (100-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and has an ultimate completion date of July 24, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,802.34 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units). This firm fixed-price delivery order, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQPDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) valued at $1,063.84 with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order was issued on September 15, 2025, with no set-aside designation. The pharmaceutical supply will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and distribution operations. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies critical medications and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, positioning it as a key provider within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/15/25 |